NET PROFIT (x1000 EUR)
EMPLOYEES
Danipharm A/S
Closing information (x1000 EUR)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
2,357
|
879
|
927 |
| Total assets |
15,145
|
12,815
|
11,693 |
| Current assets |
13,878
|
11,360
|
9,946 |
| Current liabilities |
6,329
|
6,131
|
5,879 |
| Equity capital |
8,080
|
6,244
|
5,566 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
53.4%
|
48.7%
|
47.6% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
219.3%
|
185.3%
|
169.2% |
| Return on equity (ROE) |
29.2%
|
14.1%
|
16.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.